小柴胡汤联合六味地黄丸治疗注意缺陷多动障碍患儿的疗效

doi:10.3969/j.issn.1671-7171.2025.12.026

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1198 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To investigate the clinical efficacy of Xiaochaihu Decoction combined with Liuwei Dihuang Pills in the treatment of children with attention-deficit/hyperactivity disorder (ADHD).【Methods】 A total of 90 children with ADHD were randomly assigned to either a control group or an observation group, with 45 cases in each group. The control group received relaxation training combined with psychological intervention, while the observation group received Xiaochaihu Decoction plus Liuwei Dihuang Pills in addition to the same interventions as the control group. Changes in traditional Chinese medicine (TCM) syndrome scores, serum indicators [cortisol (CORT), adrenocorticotropic hormone (ACTH), and plasma ghrelin(GHRP)], cognitive function [Wechsler Intelligence Scale for Children-Chinese Revision (WISC-CR) score], and behavioral performance [Swanson Nolan and Pelham Rating Scale-Ⅳ (SNAP-Ⅳ) score] were compared before and after treatment in the two groups.【Results】 After treatment, the observation group showed significantly lower TCM syndrome scores than the control group (P<0.05). Levels of CORT and ACTH in the observation group were lower than that in the control group, while GHRP level in the observation group were higher than that in the control group (P<0.05). WISC-CR scores were higher, and SNAP-Ⅳ scores across all dimensions were lower in the observation group compared with the control group (P<0.05).【Conclusion】 Xiaochaihu Decoction combined with Liuwei Dihuang Pills can effectively improve TCM syndrome manifestations, regulate related serum hormone levels, enhance cognitive function, and alleviate behavioral abnormalities in children with ADHD.

Key words： Attention Deficit Disorder with Hyperactivity Traditional Chinese Medicine Therapy Treatment Outcome

Received: 18 July 2025

PACS:

R742.2

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	PANG Zhongliang
	LIU Xijun
	SUN Pan
	et al

Cite this article:

PANG Zhongliang,LIU Xijun,SUN Pan, et al. Efficacy of Xiaochaihu Decoction Combined with Liuwei Dihuang Pills in the Treatment of Children with Attention Deficit Hyperactivity Disorder[J]. JOURNAL OF CLINICAL RESEARCH, 2025, 42(12): 2107-2110.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2025.12.026 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2025/V42/I12/2107

[1] 苑成浩,李明,杨丽,等. 调神益智汤、托莫西汀结合生物反馈对学龄期注意力缺陷多动障碍患儿的临床应用价值研究[J].四川中医,2024,42(5):144-148.
[2] 杨乐天,洪丹萍,党彩萍,等. 注意力和情绪调节训练对儿童注意缺陷多动障碍疗效的随机对照研究[J].新医学,2024,55(12):1035-1046.
[3] 徐宏宁,卢林阳,陈孝云,等. 放松训练结合基础心理干预对注意力缺陷多动障碍患儿注意力缺陷因子评分的影响[J].基础医学与临床,2025,45(4):522-526.
[4] 张晴,李彩英,林铭钐,等. 基于圆运动理论探究小柴胡汤辨治双心疾病[J].辽宁中医杂志,2023,50(9):42-44.
[5] 龙亚秋,袁嘉蔚. 陈宝田运用小柴胡汤、桂枝汤经验[J].广州中医药大学学报,2025,42(4):996-1000.
[6] 关郑毅.儿童注意缺陷多动障碍防治指南[M].北京:北京大学医学出版社,2007:23-24.
[7] 江育仁.实用中医儿科学[M].上海:上海科学技术出版社,2005:42-43.
[8] 国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:135-138.
[9] 尹慢慢,蒋亚林,魏冬冬,等. 盐酸哌甲酯联合行为管理治疗对注意力缺陷多动障碍儿童生长的影响[J].中国医师杂志,2024,26(8):1237-1240.
[10] 唐卓婷,于晓林,王亦辰,等. 清心平肝定志方联合哌甲酯治疗心肝火旺证注意力缺陷多动障碍患者的疗效观察[J].世界中西医结合杂志,2023,18(8):1630-1635.
[11] 徐婷,赵悦,胡博,等. 地牡宁神口服液联合阿立哌唑治疗儿童注意力缺陷多动障碍的临床研究[J].现代药物与临床,2025,40(1):86-90.
[12] 李慧,刘晓亮,苑成浩,等. 调神益智汤联合哌甲酯及脑电生物反馈治疗学龄期儿童注意力缺陷多动障碍临床观察[J].中国药业,2023,32(22):122-125.
[13] 杨燕平,李思迅,王美雯,等. 伴情绪失调的注意缺陷多动障碍患儿执行功能与临床特征[J].四川精神卫生,2024,37(4):307-311.
[14] 王珂,李优娟,李东昊. 平动汤治疗注意力缺陷多动障碍对患儿临床症状的改善评价[J].辽宁中医杂志,2025,52(2):127-131.